These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11689423)

  • 21. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
    Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
    J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1.
    Li Y; Choi M; Cavey G; Daugherty J; Suino K; Kovach A; Bingham NC; Kliewer SA; Xu HE
    Mol Cell; 2005 Feb; 17(4):491-502. PubMed ID: 15721253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the retinoid orphan-related receptor-alpha coactivator binding interface: a structural basis for ligand-independent transcription.
    Harris JM; Lau P; Chen SL; Muscat GE
    Mol Endocrinol; 2002 May; 16(5):998-1012. PubMed ID: 11981035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation.
    McInerney EM; Rose DW; Flynn SE; Westin S; Mullen TM; Krones A; Inostroza J; Torchia J; Nolte RT; Assa-Munt N; Milburn MV; Glass CK; Rosenfeld MG
    Genes Dev; 1998 Nov; 12(21):3357-68. PubMed ID: 9808623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants.
    Moraitis AN; Giguère V; Thompson CC
    Mol Cell Biol; 2002 Oct; 22(19):6831-41. PubMed ID: 12215540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.
    Wansa KD; Harris JM; Muscat GE
    J Biol Chem; 2002 Sep; 277(36):33001-11. PubMed ID: 12082103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs.
    He B; Wilson EM
    Mol Cell Biol; 2003 Mar; 23(6):2135-50. PubMed ID: 12612084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the DNA-binding and dimerization properties of the nuclear orphan receptor germ cell nuclear factor.
    Greschik H; Wurtz JM; Hublitz P; Köhler F; Moras D; Schüle R
    Mol Cell Biol; 1999 Jan; 19(1):690-703. PubMed ID: 9858592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homology modelling of the nuclear receptors: human oestrogen receptorbeta (hERbeta), the human pregnane-X-receptor (PXR), the Ah receptor (AhR) and the constitutive androstane receptor (CAR) ligand binding domains from the human oestrogen receptor alpha (hERalpha) crystal structure, and the human peroxisome proliferator activated receptor alpha (PPARalpha) ligand binding domain from the human PPARgamma crystal structure.
    Jacobs MN; Dickins M; Lewis DF
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):117-32. PubMed ID: 12710995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of Fushi tarazu factor 1 ligand binding domain/Fushi tarazu peptide complex identifies new class of nuclear receptors.
    Yoo J; Ko S; Kim H; Sampson H; Yun JH; Choe KM; Chang I; Arrowsmith CH; Krause HM; Cho HS; Lee W
    J Biol Chem; 2011 Sep; 286(36):31225-31. PubMed ID: 21775434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique functional properties of a member of the Fushi Tarazu-Factor 1 family from Schistosoma mansoni.
    Bertin B; Sasorith S; Caby S; Oger F; Cornette J; Wurtz JM; Pierce RJ
    Biochem J; 2004 Aug; 382(Pt 1):337-51. PubMed ID: 15104535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors.
    Wang Z; Benoit G; Liu J; Prasad S; Aarnisalo P; Liu X; Xu H; Walker NP; Perlmann T
    Nature; 2003 May; 423(6939):555-60. PubMed ID: 12774125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation.
    Svensson S; Ostberg T; Jacobsson M; Norström C; Stefansson K; Hallén D; Johansson IC; Zachrisson K; Ogg D; Jendeberg L
    EMBO J; 2003 Sep; 22(18):4625-33. PubMed ID: 12970175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
    Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
    Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.
    Shiau AK; Barstad D; Radek JT; Meyers MJ; Nettles KW; Katzenellenbogen BS; Katzenellenbogen JA; Agard DA; Greene GL
    Nat Struct Biol; 2002 May; 9(5):359-64. PubMed ID: 11953755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of REV-ERBβ ligand-binding domain bound to a porphyrin antagonist.
    Matta-Camacho E; Banerjee S; Hughes TS; Solt LA; Wang Y; Burris TP; Kojetin DJ
    J Biol Chem; 2014 Jul; 289(29):20054-66. PubMed ID: 24872411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanism for the potentiation of the transcriptional activity of human liver receptor homolog 1 by steroid receptor coactivator-1.
    Xu PL; Liu YQ; Shan SF; Kong YY; Zhou Q; Li M; Ding JP; Xie YH; Wang Y
    Mol Endocrinol; 2004 Aug; 18(8):1887-905. PubMed ID: 15143151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma.
    Uppenberg J; Svensson C; Jaki M; Bertilsson G; Jendeberg L; Berkenstam A
    J Biol Chem; 1998 Nov; 273(47):31108-12. PubMed ID: 9813012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
    Boerma LJ; Xia G; Qui C; Cox BD; Chalmers MJ; Smith CD; Lobo-Ruppert S; Griffin PR; Muccio DD; Renfrow MB
    J Biol Chem; 2014 Jan; 289(2):814-26. PubMed ID: 24187139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.